Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04291066Phase 2Completed
Phase 2 trial of acetylcysteine in traumatic brain injury (TBI) (2 arms), sponsored by HonorHealth Research Institute. Primary endpoint: Rivermead Post-concussion Questionnaire. Started Sep 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04291066.